Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers-Reference-Cited by-同舟云学术

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers

Published:2015-05-15 Issue:8 Volume:29 Page:931-939
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Tebas Pablo,Spitsin Sergei,Barrett Jeffrey S.,Tuluc Florin,Elci Okan,Korelitz James J.,Wagner Wayne,Winters Angela,Kim Deborah,Catalano Renae,Evans Dwight L.,Douglas Steven D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference50 articles.

1. Redefining the viral reservoirs that prevent HIV-1 eradication.;Eisele;Immunity,2012

2. Residual immune dysregulation syndrome in treated HIV infection.;Lederman;Adv Immunol,2013

3. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.;Heaton;Neurology,2010

4. Adjuvant therapies for HIV-associated neurocognitive disorders.;McGuire;Ann Clin Transl Neurol,2014

5. Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.;Douglas;Ann N Y Acad Sci,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the peripheral neural-tumour microenvironment for cancer therapy;Nature Reviews Drug Discovery;2024-09-06

2. Potential function of microRNA miRNA-206 in breast cancer pathogenesis: Mechanistic aspects and clinical implications;Pathology - Research and Practice;2024-08

3. Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System;Interdisciplinary Cancer Research;2024

4. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?;Current Medicinal Chemistry;2023-05

5. Interleukins, Chemokines, and Tumor Necrosis Factor Superfamily Ligands in the Pathogenesis of West Nile Virus Infection;Viruses;2023-03-22